enGene
Founded 1999 · 136 employees on LinkedIn · 3 known investors
Find your way into enGene
Sign up to see every warm intro you have to enGene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the enGene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Investors · 3
Founder mafia
2 people who came through enGene went on to found or lead other companies.
Related companies · 3
AdageneAdagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
OrigeneOriGene develops and manufactures research and diagnostic products, including large-scale GMP antibody production, with R&D and research manufacturing operations. It serves the life sciences and biotech research market from facilities in the US and Germany.
Enzene Biosciences LtdEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
Companies working in the same space as enGene.
In the news
Frequently asked questions
- What does enGene do?
- enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
- Who are enGene's investors?
- enGene's investors include CTI Life Sciences Fund L.P., Hercules Capital, Inc., Lumira Ventures.






